Fortrea alternatives
Companies similar to Fortrea on cro.directory, ranked by shared capabilities and locations focusing on Biologics (Monoclonal Antibodies), Small Molecule, Biologics (Other), and Vaccine. Below are the top 10 cros with overlapping structured profile data.
Shares Clinical Imaging Core Lab, China NMPA Regulatory Strategy, Japan PMDA Regulatory Strategy, and EU EMA Regulatory Strategy.
Shares China NMPA Regulatory Strategy, Japan PMDA Regulatory Strategy, EU EMA Regulatory Strategy, and US FDA Regulatory Strategy.
Shares Clinical Imaging Core Lab, China NMPA Regulatory Strategy, Japan PMDA Regulatory Strategy, and EU EMA Regulatory Strategy.
Shares Clinical Imaging Core Lab, China NMPA Regulatory Strategy, Japan PMDA Regulatory Strategy, and EU EMA Regulatory Strategy.
Shares Clinical Imaging Core Lab, EU EMA Regulatory Strategy, US FDA Regulatory Strategy, and Central Laboratory Services.
Shares China NMPA Regulatory Strategy, Japan PMDA Regulatory Strategy, EU EMA Regulatory Strategy, and US FDA Regulatory Strategy.
Shares China NMPA Regulatory Strategy, Japan PMDA Regulatory Strategy, EU EMA Regulatory Strategy, and US FDA Regulatory Strategy.
Shares EU EMA Regulatory Strategy, US FDA Regulatory Strategy, Regulatory Affairs, and Pharmacovigilance & Drug Safety.
Shares China NMPA Regulatory Strategy, Japan PMDA Regulatory Strategy, EU EMA Regulatory Strategy, and US FDA Regulatory Strategy.
Shares China NMPA Regulatory Strategy, Japan PMDA Regulatory Strategy, EU EMA Regulatory Strategy, and US FDA Regulatory Strategy.
How we pick similar companies: alternatives similarity uses shared services, modalities, locations, and site-specific capability fields — not sponsorship. Missing fields stay blank. Data comes from structured directory profiles.
Interactive comparison
Lock shared capabilities to filter peers. Locked views are not indexed — the canonical page stays unlocked.
Capability locks
- PPD
Shares Clinical Imaging Core Lab, China NMPA Regulatory Strategy, Japan PMDA Regulatory Strategy, and EU EMA Regulatory Strategy.
- Accelsiors
Shares China NMPA Regulatory Strategy, Japan PMDA Regulatory Strategy, EU EMA Regulatory Strategy, and US FDA Regulatory Strategy.
- IQVIA
Shares Clinical Imaging Core Lab, China NMPA Regulatory Strategy, Japan PMDA Regulatory Strategy, and EU EMA Regulatory Strategy.
- ICON plc
Shares Clinical Imaging Core Lab, China NMPA Regulatory Strategy, Japan PMDA Regulatory Strategy, and EU EMA Regulatory Strategy.
- Clario
Shares Clinical Imaging Core Lab, EU EMA Regulatory Strategy, US FDA Regulatory Strategy, and Central Laboratory Services.
- MMS Holdings
Shares China NMPA Regulatory Strategy, Japan PMDA Regulatory Strategy, EU EMA Regulatory Strategy, and US FDA Regulatory Strategy.
- Parexel
Shares China NMPA Regulatory Strategy, Japan PMDA Regulatory Strategy, EU EMA Regulatory Strategy, and US FDA Regulatory Strategy.
- Syneos Health
Shares EU EMA Regulatory Strategy, US FDA Regulatory Strategy, Regulatory Affairs, and Pharmacovigilance & Drug Safety.
- Premier Research
Shares China NMPA Regulatory Strategy, Japan PMDA Regulatory Strategy, EU EMA Regulatory Strategy, and US FDA Regulatory Strategy.
- Novotech
Shares China NMPA Regulatory Strategy, Japan PMDA Regulatory Strategy, EU EMA Regulatory Strategy, and US FDA Regulatory Strategy.
Markdown mirror: /alternatives/fortrea.md